Lerman Y - Search Results

1

Cost-effectiveness of varicella vaccination of healthcare workers.

Chodick G, Ashkenazi S, Livni G, Lerman Y. Chodick G, et al. Among authors: lerman y. Vaccine. 2005 Oct 17;23(43):5064-72. doi: 10.1016/j.vaccine.2005.06.004. Vaccine. 2005. PMID: 16046036

2

Hepatitis A virus seropositivity among hospital and community healthcare workers in Israel-the role of occupation, demography and socioeconomic background.

Chodick G, Ashkenazi S, Aloni H, Peled T, Lerman Y. Chodick G, et al. Among authors: lerman y. J Hosp Infect. 2003 Jun;54(2):135-40. doi: 10.1016/s0195-6701(03)00124-5. J Hosp Infect. 2003. PMID: 12818588

3

Workers' health in Israel.

Koton S, Ifrah A, Lerman Y, Ribak J, Green MS. Koton S, et al. Among authors: lerman y. Public Health Rev. 1998;26(2):189-203. Public Health Rev. 1998. PMID: 10327832

4

Seroepidemiology of varicella-zoster virus antibodies among health-care workers and day-care-centre workers.

Lerman Y, Chodick G, Tepper S, Livni G, Ashkenazi S. Lerman Y, et al. Epidemiol Infect. 2004 Dec;132(6):1135-8. doi: 10.1017/s0950268804002791. Epidemiol Infect. 2004. PMID: 15635972 Free PMC article.

5

The risk of hepatitis A infection among healthcare workers: a review of reported outbreaks and sero-epidemiologic studies.

Chodick G, Ashkenazi S, Lerman Y. Chodick G, et al. Among authors: lerman y. J Hosp Infect. 2006 Apr;62(4):414-20. doi: 10.1016/j.jhin.2005.07.018. Epub 2006 Feb 20. J Hosp Infect. 2006. PMID: 16488511 Review.

6

A graded work site intervention program to improve sun protection and skin cancer awareness in outdoor workers in Israel.

Azizi E, Flint P, Sadetzki S, Solomon A, Lerman Y, Harari G, Pavlotsky F, Kushelevsky A, Glesinger R, Shani E, Rosenberg L. Azizi E, et al. Among authors: lerman y. Cancer Causes Control. 2000 Jul;11(6):513-21. doi: 10.1023/a:1008970224998. Cancer Causes Control. 2000. PMID: 10880033 Clinical Trial.

7

The presence of hepatitis A antibodies in dental workers. A seroepidemiologic study.

Ashkenazi M, Chodik G, Littner M, Aloni H, Lerman Y. Ashkenazi M, et al. Among authors: lerman y. J Am Dent Assoc. 2001 Apr;132(4):492-8. doi: 10.14219/jada.archive.2001.0212. J Am Dent Assoc. 2001. PMID: 11315380

8

Cost-benefit analysis of active vaccination campaigns against hepatitis A among daycare centre personnel in Israel.

Chodick G, Lerman Y, Peled T, Aloni H, Ashkenazi S. Chodick G, et al. Among authors: lerman y. Pharmacoeconomics. 2001;19(3):281-91. doi: 10.2165/00019053-200119030-00006. Pharmacoeconomics. 2001. PMID: 11303416

9

Safety and immunogenicity of the oral E. coli K12-S. flexneri 2a vaccine (EcSf2a-2) among Israeli soldiers.

Cohen D, Ashkenazi S, Green MS, Yavzori M, Orr N, Slepon R, Lerman Y, Robin G, Ambar R, Block C, et al. Cohen D, et al. Among authors: lerman y. Vaccine. 1994 Nov;12(15):1436-42. doi: 10.1016/0264-410x(94)90153-8. Vaccine. 1994. PMID: 7887022 Clinical Trial.

10

Risk of exposure to hepatitis A virus among day-care workers in Israel: implications for preventive measures.

Peled T, Ashkenazi S, Chodick G, Aloni H, Yuhas Y, Lerman Y. Peled T, et al. Among authors: lerman y. Arch Environ Health. 2002 Jul-Aug;57(4):332-6. doi: 10.1080/00039890209601417. Arch Environ Health. 2002. PMID: 12530600

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results